Sponsor Pipeline

Nanjing Tianyinshan Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Early Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT06685653 Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung… NSCLC Not Yet Recruiting
Not specified
NCT06893887 Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma(HCC) Recruiting
NCT07516015 Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC NSCLC Not Yet Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Liver Cancer (1)
Get alerts when Nanjing Tianyinshan Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free